Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Extended Review For GSK’s Arzerra
GlaxoSmithKline and Genmab have announced that the FDA has informed the companies that the agency has extended the action date for the ofatumumab BLA application by three months.
GlaxoSmithKline and Genmab have announced that the FDA has informed the companies that the agency has extended the action date for the ofatumumab BLA application by three months.
Bayer has been commissioned by Berzelius, to build a sulfuric acid plant operating on the BAYQIK process. The plant has now been successfully brought on stream after just
Molecular Insight has presented clinical data on prostate cancer diagnostic at the 2009 annual meeting of the Society of Nuclear Medicine (SNM) in Toronto. The clinical data was
Alexza Pharmaceuticals has announced that it has exercised its option to purchase all of the equity of Symphony Allegro. The purchase of Symphony Allegro, which is subject to
Matrixx Initiatives has confirmed that it has received a warning letter from FDA about two of its 19 existing Zicam products – Zicam Cold Remedy Nasal Gel and
Abbott has announced the initiation of Spirit Prime, a clinical trial to study the performance of the next-generation Xience Prime Everolimus Eluting Coronary Stent System, for the treatment
Genzyme has detected a virus that impairs cell growth in one of six bioreactors at Allston Landing manufacturing facility. So, the company has decided to temporarily stop bulk
Peregrine has presented the data for ongoing trail for brain cancer at Society of Nuclear Medicine 2009 Annual Meeting. The study supports the potential for Cotara to treat
Schering-Plough has triggered its pre-existing option to extend the current collaboration with MorphoSys for another year. Schering-Plough will have continued access to MorphoSys’s proprietary antibody HuCAL GOLD, and
CeNeRx has announced the completion of $9 million financing. The financing includes a $5 million credit facility from MidCap Financial, and an additional $4 million invested by current